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Abstract Bone marrow-derived mesenchymal stem cells can
differentiate into a variety of adult cells. Brain-derived neuro-
trophic factor (BDNF) is briefly active during differentiation
and induces mesenchymal stem cells to differentiate into
nerve cells. In this study, we cloned human BDNF to generate
a recombinant pcDNA3.1(−)-BDNF vector and transfected
the vector into bone marrow-derived mesenchymal stem cells.
We selected these cells with Geneticin-418 to obtain BDNF-
BMSCs, which were induced with retinoic acid to obtain in-
duced BDNF-BMSCs. The transfected cells displayed the typ-
ical morphology and surface antigen profile of fibroblasts and
were observed to express clusters of differentiation 29, 44, and
90 (observed in matrix and stromal cells), but not clusters of
differentiation 31, 34, and 45 (observed in red blood cells and
endothelial cells), via flow cytometry. Enzyme-linked immu-
nosorbent assays showed that transfected bone marrow-
derived mesenchymal stem cells secreted more BDNF than
non-transfected bone marrow-derived mesenchymal stem
cells. Immunocytochemistry and real-time reverse transcrip-
tion polymerase chain reaction analysis showed that non-
induced BDNF-BMSCs maintained a higher proliferative ca-
pacity and expressed higher amounts of brain-derived neuro-
trophic factor, nestin, neuron-specific enolase, and glial fibril-
lary acid protein than non-transfected bone marrow-derived
mesenchymal stem cells. An additional increase was observed
in the induced BDNF-BMSCs compared to the non-induced
BDNF-BMSCs. This expression profile is characteristic of
neurocytes. Our data demonstrate that bone marrow-derived
mesenchymal stem cells transfected with the BDNF gene can
differentiate into nerve-like cells in vitro, which may enable
the generation of sufficient quantities of nerve-like cells for
treatment of neuronal diseases.
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Introduction
The treatment of neurological diseases caused by irreversible
neuronal cell damage, necrosis, or loss of neuronal cells is a
global problem. In recent years, research into cell transplanta-
tion and gene therapy has provided a novel paradigm for ad-
dressing this problem. Bone-marrow mesenchymal stem cells
(BMSCs) are multipotent stem cells (Kronenwett and Haas
2006) possessing plasticity (Grove et al. 2004) and can be
induced to differentiate into a variety of adult cell lineages,
including neurocytes (Qi et al. 2010), osteoblasts (Li et al.
2011), chondrocytes (Alves da Silva et al. 2011), and hepato-
cytes (Lange et al. 2006). Furthermore, BMSCs are easily
isolated, with low rates of transplantation rejection. Thus,
BMSCs have been deemed a resource for cell transplantation
and an effective vector for gene therapy (Li et al. 2008). The
primary limitation in the use of BMSCs is their low prevalence
in bone marrow (only 0.1%) and their propensity to differen-
tiate primarily into fibroblasts in vivo, with differentiation at
very low rates into neurocytes and gliocytes. Thus, the thera-
peutic potential of BMSCs for treating neuronal conditions is
currently severely limited.
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Neurotrophic factors, especially brain-derived neurotroph-
ic factor (BDNF), play an important role in the development,
differentiation, survival, and damage-repair of neurocytes
(Benraiss et al. 2001). It has been reported that BDNF, which
plays a primary role in the maturation, proliferation, and dif-
ferentiation of neuronal cells, can induce BMSCs to differen-
tiate into nerve cells in vivo (Brazelton et al. 2000; Lin et al.
2010) and in vitro (Zhao et al. 2004).
However, as a macromolecule, BDNF has minimal ability
to cross the blood–brain barrier and is only briefly active be-
cause of its short half-life in vivo. Previous studies have re-
ported stable growth factor expression with high expression
levels when a vector carrying the target gene is transfected into
BMSCs (Lee et al. 2001), as the BDNF gene is characterized
by continuous and stable expression and can maintain BDNF
activity for an extended period of time.
In this study, we cultured BMSCs derived from guinea pigs
in vitro and transfected the BDNF gene into the BMSCs by
electroporation. We examined the characteristics of the
transfected BMSCs. The aim of our experiments was to deter-
mine whether the BDNF gene could promote the nerve-like
cell differentiation of BMSCs in vitro.
Materials and Methods
Human BDNF clone and eukaryotic expression vector
construction. RNAwas extracted from human fetal brain tis-
sue using Trizol reagent (Life Technologies, Carlsbad, CA).
cDNA was synthesized by reverse transcription (Promega,
Madison, WI). The cycling conditions for PCR were 94°C
for 2 min; followed by 30 cycles of 95°C for 30 s, 58°C for
30 s, and 72°C for 60 s; and then 72°C for 5 min. BDNF
primers, designed with Premier 5.0 software (PREMIER
Biosoft, Palo Alto, CA), were added into a cDNA mixture
for PCR amplification (Promega). The primers used were de-
signed as follows (forward and reverse, respectively): 5′-
GCGAATTCATGACCATCCTTTTCCTTACT-3′ and 5′-
GCGGATCCTTATCTTC-CCTTTTAATGGTCAAT-3′. Af-
ter the correct product sequence was verified, the
pcDNA3.1(−) (Life Technologies) plasmid was used to gen-
erate the eukaryotic expression vector pcDNA3.1(−)-BDNF.
The recombinant plasmids were transfected into HEK293
cells (ATCC, Rockville, MD), with BDNF expression deter-
mined by western blot (Bio-Rad Laboratories, Hercules, CA).
BMSC isolation and culture. Five red-eyed white guinea pigs
weighing 250–300 g were bought from the Animal Feeding
Center of the Medical College of Jinan University, PRC. All
experimental procedures were approved by the Laboratory
Animal Management Committee of Guangdong Province.
BMSC isolation and culturing were performed as previously
reported (Wang et al. 2009). The medullary cavities of guinea
pig femurs and tibias were flushed repeatedly with Dulbecco’s
modified Eagle medium (DMEM; Gibco, Carlsbad, CA). The
cells were rinsed with lymphocyte-separating medium (main
ingredients: dextran and acid meglumine diatrizoate) and cen-
trifuged at 1,000 rpm for 20 min. The pelleted cells were re-
suspended in DMEM and re-centrifuged for an additional
10 min. The pellet (with the leukocytic cream removed) was
centrifuged at 1,000 rpm, washed twice for 10 min, and cul-
tured in DMEM containing 10% (v/v) fetal bovine serum
(FBS; Sigma, St. Louis, MO) at 37°C in a humidified atmo-
sphere containing 5% CO2. The medium was changed after
48 h, followed by removal of non-adherent cells. The cells
were passaged at a ratio of 1:2 after achieving 80% conflu-
ence, with the third passage being used in all subsequent
experiments.
BMSC identification by flow cytometry. Passage 3 BMSCs
were incubated with fluorescent-conjugated antibodies at
37°C for 1 h in the dark following two washes with
phosphate-buffered saline (PBS, 1×). Cells were analyzed
in a FACSCalibur flow cytometer using Paint-A-Gate
software (Becton Dickinson, Franklin Lakes, NJ). The
following antibodies were used: phycoerythrin (PE)-la-
beled rat anti-rat cluster of differentiation (CD) 29,
CD31, CD34, CD44, CD45, and CD90 (Santa Cruz Bio-
technology, Santa Cruz, CA).
BMSC transfection. Passage 3 BMSCs were digested and
centrifuged after adjustment of the density of the suspended
cells to 2×106/mL. Next, 0.5 mL of the cell suspension and
20 μg of pcDNA3.1(−)-BDNF were added to a 4-mm
electrotransformation pool (Bio-Rad Laboratories). Electro-
poration was performed at settings of 1050 Uf for capacitance
and 260 V for voltage. The cells were transferred into six-well
plates and cultured for 48 h after electroporation, followed by
selection with 50–200 μg/mL Geneticin (G418) sulfate
(Sigma) for 10–14 d, with a medium change every 2–3 d.
BDNF-BMSC induction and differentiation. After removal of
G418, the cells were cultured for an additional 5–7 d in
DMEM containing 15% FBS. BMSCs that were transfected
with the BDNF gene (BDNF-BMSCs) were induced by
0.5 μmol/L retinoic acid (RA; Sigma) for an additional 5 d.
BMSC and BDNF-BMSC proliferation-MTT assay. The via-
bility of the cells was measured using the 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT;
Sigma) assay. At each time point after seeding, the cells were
incubated with 5 g/L MTT for 4 h at 37°C. The formazan
granules generated by the live cells were dissolved in
150 mL of dimethyl sulfoxide (DMSO), and the absorbance
at 490 nmwas monitored using a model 550 microplate reader
(Bio-Rad Laboratories).
320 LIU ETAL.
Cell growth. As a direct cell growth assay, 5,000 cells were
seeded per well in 24-well culture plates and counted daily by
Trypan Blue exclusion dye staining (Sigma) for a 1-w period,
and cell growth curves were plotted.
Cell analysis. Cell cycle analysis was performed using
propidium iodide staining. The cell number at different phases
of the cell cycle was analyzed by a FACSCanto II flow
cytometer (Becton Dickinson). The proliferative index (PI)
was calculated according to a previously published formula
(Wang et al. 2007)
Detection of BDNF in the culture supernatant by enzyme-
linked immunosorbent assay (ELISA). The BDNF concentra-
tion in the culture supernatant of all groups was determined by
ELISA (R&DSystems,Minneapolis, MN). The culture super-
natant was collected after the cells were cultured for 1 wk,
2 wk, 1 mo, and 2 mo. The concentration of FBS in the culture
medium was decreased gradually from 15% to 10%, and then
to 5%. Finally, Mesen Cult-XF medium (Gibco) was used to
culture the cells before collection of the culture supernatant.
All reagents and working standards were prepared following
the manufacturer’s instructions. In brief, 100 μL of the super-
natant for testing was added to 96-well plates, gently mixed,
and incubated at 4°C overnight. Each well was aspirated and
washed according to the manufacturer’s instruction, and
100 μL of the diluted biotinylated anti-guinea pig BDNF
monoclonal antibody was added to each well. Subsequently,
the plate was incubated for 2 h at room temperature. Aspira-
tion and washing were repeated, and 100 μL of diluted
streptavidin–HRP was added to each well and incubated for
2 h at room temperature. After 100μL of TMB/Ewas added at
room temperature for 15 min, the reaction was stopped by
adding 50 μL of stop solution. The optical density (OD) in
each well was determinedwithin 30min by using a microplate
reader (Model 550, Bio-Rad Laboratories) at 450 nm.
Detec t ion of BDNF, nes t in , NSE, and GFAP by
immunocytochemistry. Immunocytochemistry was performed
using the SABC method (Shi et al. 1988): the culture medium
was removed from adherent cells, and the cells were then
fixed in 4% paraformaldehyde, incubated in a mixture of
30% hydrogen peroxide and pure methanol, incubated in goat
serum, and then incubated with the anti-BDNF, anti-nestin,
anti-NSE, and anti-GFAP (1:300 dilution for all; Wuhan
Boster, Wuhan, China) primary antibodies overnight in a
4°C refrigerator. The following day, incubation with the
HRP-labeled rabbit anti-mouse secondary antibody (Wuhan
Boster, Wuhan, China) was performed after rewarming of
the samples, followed by staining with streptavidin-biotin
complex (SABC; Wuhan Boster) and 3,3′-diaminobenzidine
(DAB; Wuhan Boster) and counterstaining with hematoxylin.
The samples were then dehydrated, coverslipped, and sealed.
We selected ten non-overlapping visual fields in each well by
inverted phase-contrast microscopy (Olympus, Tokyo, Japan);
positively dyed and total cells were then counted.
Analysis of BDNF, GFAP, nestin, and NSE gene expression by
real-time quantitative RT-PCR. The expression of BDNF and
neural lineage markers, including nestin, NSE, and GFAP, was
analyzed in all groups by real-time RT-PCR. Cycling condi-
tions were: 94°C for 2 min; followed by 30 cycles of 95°C for
30 s, 58°C for 30 s, and 72°C for 60 s; and finally 72°C for
5 min. The BDNF primers were described above; the other
primers usedwere as follows (forward and reverse, respective-
ly): for nestin, 5′-TCCAGAAACTCAAGCACCAC-3′ and
5′-CCACCGTATCTTCCCACCT-3′; for NSE, 5′-AACTGC
CCCTGTATCGCCA-3′ and 5′-TTTTCCGTGTAGCCAG
CCT-3′; and for GFAP, 5′-GCTTCCTGGAACAGCAAAAC
-3′ and 5′-GGCTTCATCTGCTTCCTGTC-3′.
Statistical analysis. The data are expressed as the mean±stan-
dard deviation (x SD). Statistical analysis was performed
using SPSS 15.0 statistical software (Chicago, IL). ANOVA
was employed for comparison among groups. P<0.05 was
considered statistically significant.
Results
Construction of BDNF gene-containing eukaryotic expression
vector. The coding sequence of BDNF was generated by RT-
PCR (Fig. 1A). The eukaryotic expression vector
pCDNA3.1(−)-BDNF was then successfully constructed.
BDNF was confirmed to be present in HEK293 cells
transfected with the pcDNA3.1(−)-BDNF plasmid. The size
of the protein band conformed to that expected (Fig. 1B).
BMSC phenotype identification. Flow cytometric analysis
demonstrated that BMSCs at passage 3 expressed CD29,
CD44, and CD90 (biomarkers of BMSCs) but not CD31,
CD34, and CD45 (Fig. 2), indicating that the BMSCs were
of high purity.
BMSC morphology and post-transfection change. After 72 h
of culture, the adherent cells were primarily characterized by
their long spindle shape and large, single nucleus, similar to
fibroblasts. However, spherical hematopoietic cells existed in
suspension. Roughly 2 wk later, the adherent cells were over-
grown in the flask bottom, with a monolayer that was mutu-
ally fused among cell colonies, and arranged with certain di-
rectionality (Fig. 3A). The cellular morphology remained the
same after passaging, although the rate of cellular proliferation
gradually decreased with greater passage number. BMSC
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morphology and density did not change markedly after induc-
tion by RA (Fig. 3B).
Some BMSCs died after electroporation. After culture for
48 h, the viability of the transfected BMSCs was obviously
higher than that of nontransfected BMSCs. Only cells
transfected with BDNF survived G418 treatment. The trans-
fection efficiency was approximately 28%. At 3–4 d after
transfection, the cell density was still lower than that in non-
transfected cells. Some surviving cells presented polygonal,
fusiform, or ovoid shapes, along with cytoplasm retraction
and concentration toward the nucleus together with a protrud-
ed soma (with the longer protruding end swelling into a cone
shape) and a neuron-like form (Fig. 3C). Subsequently, the
number of amoeboid cells increased at a slower rate, with cells
returning to normal growth rate under appropriate conditions
at 5–7 d after G418 removal. The number of amoeboid
BDNF-BMSCs increased further after RA addition, with ap-
parent cellular protuberances, and in some cases, cellular net-
works (Fig. 3D).
Proliferation analysis. The following groups of BMSCs were
analyzed: BMSCs that were neither BDNF-transfected nor
RA-induced (non-induced BMSCs, a negative control group),
BMSCs that were RA-induced (induced BMSCs), BDNF-
BMSCs that were transfected but not RA-induced (non-
induced BDNF-BMSCs), and BDNF-BMSCs that were RA-
induced (induced BDNF-BMSCs).
The effect of the BDNF gene on BMSC proliferation in
BMSCs and BDNF-BMSCs was determined using the MTT
assay. At 48, 96, and 144 h post-seeding, there was no notable
variation in viability between non-induced and induced
BMSCs, whereas non-induced BDNF-BMSCs displayed a
significant increase in viability compared with non-induced
and induced BMSCs. An additional increase in viability was
observed in induced BDNF-BMSCs compared to uninduced
BDNF-BMSCs (P<0.05; Fig. 4A). Similar results were ob-
tained for cell counts from days 2 to 7 (P<0.05; Fig. 4B).
Moreover, cell cycle analysis showed that BDNF-BMSCs
were present in apparently lower proportions in the G0/G1
phase and higher proportions in the S and G2/M phases com-
pared to BMSCs (Fig. 4C, Table 1). The proliferative index
(PI) of BDNF-BMSCs increased significantly compared with
that of BMSCs (P<0.05; Table 1).
BDNF secretion. BMSCs (induced or non-induced) secreted
BDNF at 1 wk. BDNF secretion gradually decreased with
time and was almost undetectable at 2 mo. There was
an obvious increase in BDNF secretion from non-
induced BDNF–BMSCs compared with BMSCs at each
time point, with differences of 661-fold (1 wk), 1,317-
Figure 1 Coding sequence (CDS) of the BDNF gene and expression of
pcDNA3.1(−)-BDNF in HEK293 cells. (A) BDNF gene CDS. The CDS
of the BDNF gene can be clearly observed (M: DL2000 DNAMarker, 1:
BDNF CDS). (B) Expression of pcDNA3.1(−)-BDNF in HEK293 cells.
BDNF was detected by western blot in HEK293 cells transfected with
pcDNA3.1(−)-BDNF, but not in HEK293 cells transfected with
pcDNA3.1(−) (CON: HEK293 cells transfected with pcDNA3.1(−),
BDNF: HEK293 cells transfected with pcDNA3.1(−)-BDNF).
Figure 2 Flow cytometric analysis of third-passage BMSCs. (A–C)
BMSCs were positive for CD29, CD44, and CD90 staining. (D–E)
BMSCs were negative for CD34, CD45, and CD31 staining.
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fold (2 wk), 1,728-fold (1 mo), and 4,094-fold (2 mo)
compared with the non-induced BMSCs. There was also
an increase, although not significant, in the BDNF con-
centration in induced BDNF-BMSCs compared to non-
induced BDNF–BMSCs. The maximum BDNF secretion
of BDNF–BMSCs (induced or non-induced) was
observed at 2 wk, although BDNF expression was still
observed even at 2 mo (Table 2).
Immunocytochemistry. Immunocytochemical analysis
showed that non-induced BMSCs expressed low levels of
BDNF, nestin, NSE, and GFAP (Fig. 5A1–A4). Similarly,
Figure 3 BMSC morphology and its change after transfection
(magnification, ×100). (A) First generation of BMSCs. BMSCs cultured
for 12 d were primarily characterized by long spindles and arranged with
certain directivity. (B) RA-induced BMSCs. BMSC morphology and
density did not markedly change after induction by RA. (C) Transfected
BMSCs. Some BMSCs showed deformation after transfection with the
human BDNF gene and treatment with G418, with a protruded soma and
nerve-like form. (D) Induced BDNF-BMSCs. More BDNF-BMSCs dif-
ferentiated and were deformed upon induction with retinoic acid (RA),
where protruded soma were more apparent, and several cells were retic-
ulated by connecting with one another.
Figure 4 Proliferation in BMSCs of BDNF-BMSCs. (A) Proliferation
was determined by MTTassay at 48, 96, and 144 h. Values are presented
as the mean±SD for three independent experiments. (B) Growth curves.
BDNF-BMSCs displayed a higher growth rate than BMSCs from days 2
to 7. The points represent the mean±SD for triplicate experiments. (C)
Representative histograms of flow cytometric analysis for cell cycle dis-
tribution. The proportion of BDNF-BMSCs in the S and G2/M phases
was higher and that in the G0/G1 phases was lower than that in BMSCs.
#P<0.05, compared with BMSCs (induced or non-induced). *P<0.05,
compared with non-induced BDNF-BMSCs.
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low levels of BDNF, nestin, NSE, and GFAP were detected in
induced BMSCs (Fig. 5B1–B4). By contrast, over 98% of
non-induced BDNF-BMSCs (Fig. 5C1) and induced BDNF-
BMSCs (Fig. 5D1) stained positively for BDNF. The number
of cells positively co-stained for nestin, NSE, and GFAP was
significantly higher in non-induced BDNF-BMSCs than in
BMSCs (Fig. 5C2–C4). Furthermore, a higher number of cells
positively co-stained for nestin, NSE, and GFAP were detect-
ed in induced BDNF-BMSCs than in non-induced BDNF-
BMSCs (Fig. 5D2–D4).
BMSCs (induced or non-induced) expressed low levels of
BDNF, nestin, NSE, and GFAP, whereas BDNF-BMSCs
(induced or non-induced) expressed higher levels of BDNF,
nestin, NSE, and GFAP (P<0.01). Furthermore, more cells
positively co-stained with nestin, NSE, and GFAP were de-
tected in induced BDNF-BMSCs than in non-induced BDNF-
BMSCs (P<0.05) (Fig. 5E).
mRNA expression. To further confirm secretion and neuro-
nal differentiation in BMSCs and BDNF-BMSCs, we ana-
lyzed the mRNA expression levels of BDNF and specific
biomarkers of neuronal differentiation (i.e., nestin, NSE,
and GFAP) by real-time quantitative RT-PCR. The results
were consistent with the immunocytochemistry results.
Compared with non-induced BMSCs, the mRNA expres-
sion levels of BDNF, nestin, NSE, and GFAP in non-
induced BDNF-BMSCs were 8.66-, 2.67-, 6.22-, and
2.58-fold (P<0.01) higher, respectively. Moreover, the
levels of nestin, NSE, and GFAP mRNA in induced
BDNF-BMSCs were 1.92-, 2.04-, and 2.11-fold (P<0.05)
higher, respectively, than those in non-induced BDNF-
BMSCs (Fig. 6).
Discussion
BMSCs are derived from mesoblasts, adhere to the walls of
tissue culture flasks, and possess a spindle morphology with
fibroblast-forming colonies (Jiang et al. 2002). Our findings
indicate that BMSCs do not express antigens observed on the
surface of red blood cells and endothelial cells (e.g., CD31,
CD34, and CD45), but express specific surface markers of
matrix and stromal cells (e.g., CD29, CD44, and CD90)
(Baddoo et al. 2003; Herzog et al. 2003). These findings agree
with the accreditation standards of animal-origin BMSCs pub-
lished by the International Society for Cell Therapy (Dominici
et al. 2006). The particular mechanism of BMSC cross-germ-
layer differentiation into neurons, which are derived from
ectoblasts, remains unclear. Undifferentiated BMSCs express
not only mesodermal but also endodermal and ectodermal
genes. Therefore, BMSCs are capable of producing mesoder-
mal derivatives and perhaps also ectodermal derivatives
through transformation, which may be the basis for cross-
germ-layer differentiation (Woodbury et al. 2002).
It has been confirmed that the amino acid sequences of
mammalian BDNF (Zhang et al. 2006), TrkB, and the p75
receptor (Dobrzańska et al. 2002) are highly homologous
and conserved with regard to tissue distribution. Human and
guinea pigs are both mammals. Therefore, we transfected the
BMSCs of guinea pigs with the human BDNF gene in the
study, expecting that the human BDNF would have an effect
on guinea pigs.
Under normal circumstances, BMSCs secrete low
levels of BDNF, and few differentiate into neurocytes.
This conclusion is supported by the observation that
non-induced BMSCs were, en toto, only slightly positive
by immunocytochemistry and had low levels of mRNA
Table 1 Cell cycle distribution of BMSCs and BDNF-BMSCs (in per-
cent; mean±SD)
Cell G0/G1 G2/M S PI
Non-induced
BMSCs
86.13±3.61 0.71±0.22 13.15±1.56 14.08±2.32
Induced
BMSCs








68.23±2.65b 2.03±0.35b 29.73±2.36b 34.69±3.62b
aP<0.05, compared with BMSCs (induced or non-induced)
bP<0.05, compared with non-induced BDNF-BMSCs
Table 2 BDNF concentration in the culture medium of BMSCs and BDNF-BMSCs (in picogram per milliliter; mean±SD)
Time 1 wk 2 wk 1 mo 2 mo
Cell
Non-induced BMSCs 2.5±1.30 1.5±0.72 0.8±0.48 0.2±0.19
Induced BMSCs 2.7±1.49 1.6±0.51 0.8±0.73 0.3±0.32
Non-induced BDNF-BMSCs 1671.3±138.70a 1988.5±187.29a 1391.1±102.46a 825.9±91.28a
Induced BDNF-BMSCs 1738.5±140.14a 2103.3±162.37a 1584.5±129.49a 981.9±77.83a
aP<0.01, compared with BMSCs (induced or non-induced)
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expression for BDNF, nestin, NSE, and GFAP in our ex-
periments. The differentiation pathways of BMSCs are
affected by a variety of factors, including differentiation
signals, growth factor types in a given microenvironment,
and the extracellular matrix (Deng et al. 2001; Seki
2003). The mechanism by which clinicians may induce
Figure 5 Immunocytochemical analysis of BMSCs and BDNF-BMSCs
(brown staining highlighted by arrows, magnification ×200). (A1–A4)
Non-induced BMSCs expressed low levels of BDNF, nestin, NSE, and
GFAP. (B1–B4) Low levels of BDNF, nestin, NSE, and GFAP were also
detected in induced BMSCs. (C1–C4) The number of cells positively co-
stained with BDNF, nestin, NSE, and GFAP in non-induced BDNF-
BMSCs was significantly higher than that in BMSCs. Over 98% of
non-induced BDNF-BMSCs were positively stained for BDNF. (D1–
D4) Over 98% of induced BDNF-BMSCs were positively stained for
BDNF. More cells positively co-stained for nestin, NSE, and GFAP were
detected in induced BDNF-BMSCs than in non-induced BDNF-BMSCs.
(E) Rates of positive immunostaining in BMSCs and BDNF-BMSCs, as
determined by immunocytochemistry for BDNF, nestin, NSE, and GFAP
(%; mean±SD). #P<0.01 compared with non-induced BMSCs and in-
duced BMSCs; *P<0.05 compared with non-induced BDNF-BMSCs.
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BMSCs to differentiate into target cells has been the sub-
ject of intensive research in cellular transplantation and
gene therapy.
In the present study, BMSCs were transfected with the
BDNF gene. With continuous BDNF expression, the
transfected BMSCs displayed significantly higher prolifera-
tive capacity, more BDNF secretion, and a higher proportion
of differentiation into nerve-like cells than primary BMSCs.
Differentiated BDNF-BMSCs possessed the morphological
features of neuronal cells and expressed the neuronal cell-
specific markers nestin, NSE, and GFAP. Nestin is a neuronal
stem cell-specific marker protein, whereas NSE and GFAP are
neuron- and astrocyte-specific markers, respectively.
The immunoreactivity and mRNA expression levels of
nestin, NSE, and GFAP were higher in BDNF-BMSCs
(induced or non-induced) than in BMSCs (induced or non-
induced). Moreover, the immunoreactivity and mRNA ex-
pression level of NSE were greater than those of GFAP in
BDNF-BMSCs (induced or non-induced), indicating that
BDNF-BMSCs possessed characteristics of neuronal cells
and suggesting that BDNF overexpression could enhance
the differentiation of BMSCs into nerve-like cells, principally
into neuron-like cells. These observations are consistent with
previously reported studies (Jouhilahti et al. 2008). Although
the mechanism underlying the BDNF-mediated enhancement
of proliferation and differentiation remains unclear, it has been
widely reported that BDNF binds to HNGFRTrkB or LNGFR
P75NGFR on the membranes of BMSCs, activating tyrosine
kinase (TK) and subsequently activating intracellular signal-
ing pathways such as those involving mitogen-activated pro-
tein kinase (MAPK), calmodulin kinase (CaMK), and
phosphatidylinositol-3-kinase (PI3K). This process causes
BMSCs to proliferate more rapidly and differentiate from un-
differentiated cells into mature neurons (Lu 2003; Tapia-
Arancibia et al. 2004; Chai et al. 2007).
RA can induce cells to proliferate and differentiate by acti-
vating signal transduction upon binding to retinoic acid
receptors (RARs) on the nuclear membrane, thereby affecting
the transcriptional regulation of downstream genes and exerting
biological effects (Nezzar et al. 2007). RA also enhances the
expression of RARβ and the transcription factor islet-1/2,
which is important for neural development. It is therefore used
in neuronal induction media to promote the proliferation and
differentiation of BMSCs into nerve-like cells (Bi et al. 2010).
In our experiment, the immunoreactivity and mRNA expres-
sion levels of nestin, NSE, and GFAP in induced BDNF-
BMSCs were higher than those in non-induced BDNF-
BMSCs, consistent with the results of Bi et al. (2010). RA
induces TrkB expression and switches on the TrkB-BDNF sig-
nal transduction pathway, enhancing the inductive effect of
BDNF on cell differentiation (Kaplan et al. 1993). However,
RA is a chemical reagent and thus has concentration-dependent
effects. In particular, it has little effect on cells at low concen-
trations (for example, 0.5 μmol/L), whereas it has cytotoxic
effects such as teratogenesis and apoptosis at high concentra-
tions (Lu et al. 2009). To prevent toxicity, we treated the cells
with a low concentration of RA (0.5 μmol/L). Thus, in this
study, the RA did not have a marked effect on BMSCs. How-
ever, it evidently promoted the proliferation and differentiation
of BDNF-BMSCs synergistically with BDNF.
Conclusions
In conclusion, we have confirmed that BDNF enhances the
differentiation of BMSCs into nerve-like cells in vitro. We
examined the characteristics of the differentiated nerve-like
cells with regard to morphological features, BDNF secretion,
and expression of neural cell markers. Some investigators
have evaluated whether the differentiated cells possess the
structural and functional characteristics of neuronal cells
based on the ultrastructural and electrophysiological aspects
of the cells, obtaining promising, although preliminary, results
(Akiyama et al. 2002). The cellular differentiation mecha-
nisms will be the focus of future research. The present findings
may be useful for the treatment of nervous system diseases.
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